SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-13-005169
Filing Date
2013-04-30
Accepted
2013-04-30 14:56:23
Documents
6
Period of Report
2013-06-19
Effectiveness Date
2013-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2214653zdef14a.htm DEF 14A 381235
2 G651724.JPG g651724.jpg GRAPHIC 10236
3 G103642MA01I001.GIF g103642ma01i001.gif GRAPHIC 106479
4 G103642MA01I002.GIF g103642ma01i002.gif GRAPHIC 46044
5 G103642MA03I001.GIF g103642ma03i001.gif GRAPHIC 55708
6 G103642MA03I002.GIF g103642ma03i002.gif GRAPHIC 45185
  Complete submission text file 0001047469-13-005169.txt   746302
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE NEW YORK NY 10022 212-831-1111
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35619 | Film No.: 13796702
SIC: 2834 Pharmaceutical Preparations